what meds are glp 1 New GLP-1 Guidelines for Type 2 Diabetes in 2025 What to Make of the

Observational Studies on GLP-1R Agonists and Substance Use Outcomes The clinical potential of GLP-1RAs in modulating substance use behaviors has been increasingly recognized through preclinical and early translational studies

There are also many multi-target dual agonists under development, such as GLP-1R/GCGR, GLP-1R/fibroblast growth factor 21 receptor (FGF21R), etc

The stronger evidence for dementia prevention still centers on the basics that are easy to underestimate: blood pressure, lipids, glucose regulation, physical activity, sleep, hearing, vision, nutrition, social connection, and inflammation control

However, the incidence of gastrointestinal events, discontinuations due to adverse events, and mean increase in pulse rate were higher with orforglipron than oral semaglutide